Ubon Bio Ethanol PCL
SET:UBE
Balance Sheet
Balance Sheet Decomposition
Ubon Bio Ethanol PCL
Ubon Bio Ethanol PCL
Balance Sheet
Ubon Bio Ethanol PCL
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
115
|
55
|
63
|
145
|
476
|
94
|
393
|
487
|
|
| Cash |
0
|
0
|
0
|
0
|
476
|
94
|
393
|
487
|
|
| Cash Equivalents |
115
|
55
|
63
|
145
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
101
|
161
|
11
|
0
|
|
| Total Receivables |
492
|
556
|
393
|
419
|
834
|
850
|
536
|
469
|
|
| Accounts Receivables |
369
|
419
|
334
|
356
|
755
|
789
|
443
|
418
|
|
| Other Receivables |
123
|
138
|
59
|
63
|
79
|
61
|
92
|
51
|
|
| Inventory |
906
|
1 058
|
1 007
|
1 142
|
918
|
955
|
1 121
|
1 140
|
|
| Other Current Assets |
39
|
255
|
172
|
55
|
86
|
310
|
283
|
155
|
|
| Total Current Assets |
1 553
|
1 924
|
1 635
|
1 761
|
2 415
|
2 370
|
2 344
|
2 251
|
|
| PP&E Net |
5 737
|
5 528
|
5 276
|
5 081
|
4 758
|
4 720
|
4 741
|
4 542
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
4 758
|
4 720
|
4 741
|
4 542
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
3 011
|
3 404
|
3 780
|
4 106
|
|
| Intangible Assets |
21
|
26
|
24
|
23
|
20
|
14
|
30
|
48
|
|
| Note Receivable |
48
|
68
|
54
|
19
|
10
|
16
|
18
|
9
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
5
|
5
|
0
|
0
|
|
| Other Long-Term Assets |
15
|
14
|
14
|
19
|
22
|
95
|
134
|
414
|
|
| Total Assets |
7 373
N/A
|
7 560
+3%
|
7 003
-7%
|
6 902
-1%
|
7 229
+5%
|
7 219
0%
|
7 266
+1%
|
7 265
0%
|
|
| Liabilities | |||||||||
| Accounts Payable |
20
|
39
|
33
|
30
|
142
|
201
|
128
|
179
|
|
| Accrued Liabilities |
9
|
6
|
14
|
16
|
122
|
120
|
104
|
85
|
|
| Short-Term Debt |
2 738
|
2 436
|
2 371
|
2 453
|
0
|
0
|
657
|
331
|
|
| Current Portion of Long-Term Debt |
127
|
101
|
57
|
64
|
365
|
389
|
341
|
229
|
|
| Other Current Liabilities |
375
|
198
|
118
|
135
|
34
|
34
|
50
|
74
|
|
| Total Current Liabilities |
3 269
|
2 779
|
2 593
|
2 697
|
663
|
745
|
1 281
|
898
|
|
| Long-Term Debt |
1 135
|
1 743
|
1 412
|
1 117
|
782
|
455
|
217
|
293
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
82
|
|
| Other Liabilities |
28
|
29
|
32
|
32
|
35
|
26
|
27
|
59
|
|
| Total Liabilities |
4 432
N/A
|
4 551
+3%
|
4 037
-11%
|
3 846
-5%
|
1 480
-62%
|
1 226
-17%
|
1 526
+24%
|
1 332
-13%
|
|
| Equity | |||||||||
| Common Stock |
2 740
|
2 740
|
2 740
|
2 740
|
3 914
|
3 914
|
3 914
|
3 914
|
|
| Retained Earnings |
201
|
269
|
226
|
315
|
266
|
511
|
258
|
450
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
1 568
|
1 568
|
1 568
|
1 568
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2 941
N/A
|
3 009
+2%
|
2 966
-1%
|
3 055
+3%
|
5 749
+88%
|
5 994
+4%
|
5 741
-4%
|
5 933
+3%
|
|
| Total Liabilities & Equity |
7 373
N/A
|
7 560
+3%
|
7 003
-7%
|
6 902
-1%
|
7 229
+5%
|
7 219
0%
|
7 266
+1%
|
7 265
0%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1 280
|
1 280
|
1 280
|
1 280
|
3 914
|
3 914
|
3 914
|
3 914
|
|